Mehdi Gasmi, Director at Adverum Biotechnologies, Inc. (ADVM), sold 15,000 shares at $23.00 ($324K) on 2020-06-15, disclosed to the SEC on 2020-06-17.
Open-market sale of $324k ADVM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.01 | 5,000 | $105K | 32.5% |
| 2 | $21.01 | 5,000 | $105K | 32.5% |
| 3 | $21.93 | 1,416 | $31K | 9.6% |
| 4 | $23.00 | 3,425 | $79K | 24.3% |
| 5 | $23.59 | 159 | $4K | 1.2% |
| Total | $21.58 avg | 15,000 |
| $324K |
| 100% |
| Filing → |
| ADVM | SELL | 2020-06-18 | $563K | — | Filing → |
| ADVM | SELL | 2020-05-22 | $100K | — | Filing → |
| ADVM | SELL | 2020-05-20 | $917K | — | Filing → |